Merck & Co (NYSE: MRK)

DRUGS - Drug Manufacturers - Major

Health Care

Stock price data as of

Closing price: $121.41
  • Support level
    $108.75
  • Resistance level
    N/A
  • Beta
    0.1
  • RSI (14-day)
    77.2
  • MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
  • The price of this low-beta stock is expected to increase by 0.1 percent for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.
  • With RSI > 70, MRK is overbought. Odds slightly favor a short-term price reversal.
  • Price broke above prior resistance level - a short-term bullish signal.

52-week range

52-week low 52-week high Price as % of range
$73.47 $121.93 99.2%

Moving averages

200 day 50 day 20 day 10 day
$89.76 $108.00 $113.58 $118.40

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    5.9%
  • In the next month
    13.1%
  • In the next year
    58.1%

Volatility estimates (annualized standard deviations)

Period Value
Historical (5 year) 23.2%
Last month 27.8%
Current estimate 21.7%
Next month forecast 23.2%